Related news for:   cancer care

Professor John Hooper and his team based at TRI, receives accolade that will allow them to progress ovarian cancer research to clinical trial.

30

Apr

Accolade for ovarian cancer research achievement

A drug currently in clinical trials has the potential to improve the survival rate of Australians diagnosed with acute myeloid leukaemia.

28

Apr

Mater research shows positive signs for acute myeloid leukaemia patients

Researchers from Mater Research are pioneering a new approach to symptom relief by trialling medicinal cannabis in advanced cancer patients, as part of an Australian-first trial.

22

Apr

Researchers trial medicinal cannabis treatment for advanced cancer patients

Mater Researcher Dr Felicity Davis has been awarded one of two $50,000 Metcalf Prizes from the National Stem Cell Foundation of Australia.

05

Nov

Dr Felicity Davis awarded Metcalf prize

A Mater researcher has developed a method to predict breast cancer patient responses to a commonly prescribed breast cancer drug.

04

Feb

New test predicts breast cancer patients at risk of relapse

Prof John Hooper & his team are working towards improving the diagnosis & treatment of ovarian cancer by developing a unique PET imaging agent that shows the exact location and extent of the tumour.

14

Aug

Increasing the visibility of cancer

Dr Cameron Turtle, a leading hematology oncologist and bone marrow transplant specialist at the Fred Hutchinson Cancer Research Center returned to Mater Research to share his latest research.

20

Mar

From Brisbane to Washington: former Mater researcher returns to share advances in cancer research

A Queensland trial will evaluate the benefits of medicinal cannabis for symptom relief in cancer patients receiving palliative care.

31

Jan

Medicinal cannabinoids trial for symptom relief